Menin-MLL inhibitor 20 是一种不可逆的 menin-MLL 相互作用的抑制剂,具有抗肿瘤活性 (WO2020142557A1, compound 6)。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6)[1].
The Histone-lysine N-methyltransferase 2 (KMT2) family of proteins, which currently consists of at least 5 members, methylate ly sine 4 on the histone H3 tails at important regulatory regions in the genome and thereby impart crucial functions through the modulation of chromatin structures and DNA accessibility. These enzymes are known to play an important role in the regulation of gene expression during early development and hematopoiesis. The human KMT2 family was initially named the mixed-lineage leukaemia (MLL) family, owing to the role of the first-found member in this disease[1].
[1]. Thomas Butler, et al. Irreversible inhibitors of menin-mll interaction. WO2020142557A1.
没有评价数据